Marpai (MRAI) Receives a Buy from Maxim Group
TipRanks · 6d ago
Insurance Stocks Moving In Wednesday's Intraday Session
Benzinga · 03/15 17:40
Insurance Stocks Moving In Thursday's Intraday Session
Benzinga · 03/02 17:40
Insurance Stocks Moving In Monday's Intraday Session
Benzinga · 02/27 17:40
Marpai (MRAI) Gets a Buy from Maxim Group
TipRanks · 02/25 12:35
Insurance Stocks Moving In Friday's Intraday Session
Benzinga · 02/24 17:40
Insurance Stocks Moving In Tuesday's Intraday Session
Benzinga · 02/21 17:40
Marpai hires COO
Seeking Alpha · 02/07 13:16
Marpai Names Gonen Antebi COO
Marpai Names Gonen Antebi COO
MT Newswires · 02/07 12:49
Maxim Group Remains a Buy on Marpai (MRAI)
TipRanks · 01/31 12:35
Marpai Files $100 Million Mixed Shelf
Marpai Files $100 Million Mixed Shelf
MT Newswires · 01/23 04:01
BRIEF-Marpai Inc Files For Mixed Shelf Of Up To $100 Mln - SEC Filing
Reuters · 01/20 21:05
Webull provides a variety of real-time MRAI stock news. You can receive the latest news about Marpai Inc through multiple platforms. This information may help you make smarter investment decisions.
About MRAI
Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI). The Company provides administrative services, and act as third-party-administrator (TPA) to self-insured employers who provides healthcare benefits to their employees. The Company’s clients are small and medium-sized companies, as well as local government entities. It provides services to a total of approximately 20,000 of its clients’ employees, and including their spouses and dependents, it serves a total of approximately 40,000 members in 44 states in addition to the District of Columbia. The Company’s AI-powered TopCare program became live, making it possible for it to offer care management with predictions. Its AI technology is able to process, analyze and store myriad types of data in large scale. The Company’s AI models, collectively branded as FutureSight Advantage, recognize patterns and detect anomalies, giving it insights on a patient’s medical trajectory.